These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9133756)

  • 21. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium.
    Yoshimura R; Ueda N; Shinkai K; Nakamura J
    Pharmacopsychiatry; 2006 Nov; 39(6):233-4. PubMed ID: 17124648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium in the long-term treatment of bipolar disorders.
    Kleindienst N; Greil W
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed or dysphoric manic states: psychopathology and treatment.
    Swann AC
    J Clin Psychiatry; 1995; 56 Suppl 3():6-10. PubMed ID: 7883742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between concurrent psychotropic medications and self-reported adherence with taking a mood stabilizer in bipolar disorder.
    Bauer M; Glenn T; Grof P; Marsh W; Sagduyu K; Alda M; Murray G; Lewitzka U; Schmid R; Haack S; Whybrow PC
    Hum Psychopharmacol; 2010 Jan; 25(1):47-54. PubMed ID: 20033908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintenance lithium treatment: side effects and compliance.
    Gitlin MJ; Cochran SD; Jamison KR
    J Clin Psychiatry; 1989 Apr; 50(4):127-31. PubMed ID: 2925600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of therapeutic modalities for mania.
    Small JG; Klapper MH; Milstein V; Marhenke JD; Small IF
    Psychopharmacol Bull; 1996; 32(4):623-7. PubMed ID: 8993083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compliance during lithium treatment, intra-erythrocyte lithium variability, and relapse.
    Harvey NS; Kay R
    J Clin Psychopharmacol; 1991 Dec; 11(6):362-7. PubMed ID: 1770155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to pharmacological treatment for juvenile bipolar disorder.
    Drotar D; Greenley RN; Demeter CA; McNamara NK; Stansbrey RJ; Calabrese JR; Stange J; Vijay P; Findling RL
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):831-9. PubMed ID: 17581447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The puzzle of noncompliance in the manic patient.
    Goldman DL; Post RM
    Bull Menninger Clin; 1991; 55(2):248-53. PubMed ID: 2043901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment adherence in individuals with rapid cycling bipolar disorder: results from a clinical-trial setting.
    Sajatovic M; Elhaj O; Youngstrom EA; Bilali SR; Rapport DJ; Ganocy SJ; Calabrese JR
    J Clin Psychopharmacol; 2007 Aug; 27(4):412-4. PubMed ID: 17632236
    [No Abstract]   [Full Text] [Related]  

  • 32. [Rapid cycling in bipolar disorders].
    Knoppert-van der Klein EA; Hoogduin CA; Nolen WA
    Ned Tijdschr Geneeskd; 1994 Jan; 138(3):145-8. PubMed ID: 8295640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting treatment compliance in patients with bipolar I disorder during prophylaxis: a study from Turkey.
    Col SE; Caykoylu A; Karakas Ugurlu G; Ugurlu M
    Gen Hosp Psychiatry; 2014; 36(2):208-13. PubMed ID: 24359677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication compliance among patients with bipolar disorder and substance use disorder.
    Weiss RD; Greenfield SF; Najavits LM; Soto JA; Wyner D; Tohen M; Griffin ML
    J Clin Psychiatry; 1998 Apr; 59(4):172-4. PubMed ID: 9590667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study.
    Kleindienst N; Greil W
    Neuropsychobiology; 2000; 42 Suppl 1():2-10. PubMed ID: 11093063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of chronic lithium treatment on retinal electrophysiologic function.
    Lam RW; Allain S; Sullivan K; Beattie CW; Remick RA; Zis AP
    Biol Psychiatry; 1997 Mar; 41(6):737-42. PubMed ID: 9066998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profile of a sample of subjects admitted to an acute care psychiatric facility with manic symptoms.
    Marken PA; Stanislav SW; Lacombe S; Pierce C; Hornstra R; Sommi RW
    Psychopharmacol Bull; 1992; 28(2):201-5. PubMed ID: 1513925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is it time to have another look at lithium maintenance therapy in bipolar disorder?
    Akhondzadeh S; Emamian ES; Ahmadi-Abhari A; Shabestari O; Dadgarnejad M
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):1011-7. PubMed ID: 10621946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimanic and mood-stabilizing effect of memantine as an augmenting agent in treatment-resistant bipolar disorder.
    Koukopoulos A; Reginaldi D; Serra G; Koukopoulos A; Sani G; Serra G
    Bipolar Disord; 2010 May; 12(3):348-9. PubMed ID: 20565444
    [No Abstract]   [Full Text] [Related]  

  • 40. [Successful lithium treatment of manic-like symptoms in multiple sclerosis].
    Weizsäcker M; Tegeler J
    Nervenarzt; 1984 Apr; 55(4):214-6. PubMed ID: 6427639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.